Christopher Heery - Net Worth and Insider Trading
Christopher Heery Net Worth
The estimated net worth of Christopher Heery is at least $2 Million dollars as of 2025-05-09. Christopher Heery is the CHIEF MEDICAL OFFICER of Arcellx Inc and owns about 37,486 shares of Arcellx Inc (ACLX) stock worth over $2 Million. Christopher Heery is also the Chief Medical Officer of Precision BioSciences Inc and owns about 83 shares of Precision BioSciences Inc (DTIL) stock worth over $427. Details can be seen in Christopher Heery's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Heery has not made any transactions after 2025-02-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Heery
Christopher Heery Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Heery owns 2 companies in total, including Precision BioSciences Inc (DTIL) , and Arcellx Inc (ACLX) .
Click here to see the complete history of Christopher Heery’s form 4 insider trades.
Insider Ownership Summary of Christopher Heery
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| DTIL | Precision BioSciences Inc | 2019-12-19 | Chief Medical Officer |
| ACLX | Arcellx Inc | 2025-02-24 | Chief Medical Officer |
Christopher Heery Latest Holdings Summary
Christopher Heery currently owns a total of 2 stocks. Among these stocks, Christopher Heery owns 37,486 shares of Arcellx Inc (ACLX) as of February 24, 2025, with a value of $2 Million and a weighting of 99.98%. Christopher Heery also owns 83 shares of Precision BioSciences Inc (DTIL) as of December 19, 2019, with a value of $427 and a weighting of 0.02%.
Latest Holdings of Christopher Heery
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACLX | Arcellx Inc | 2025-02-24 | 37,486 | 56.26 | 2,108,962 |
| DTIL | Precision BioSciences Inc | 2019-12-19 | 83 | 5.15 | 427 |
Holding Weightings of Christopher Heery
Christopher Heery Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Heery has made a total of 31 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 31 sells. The most-recent trade in Arcellx Inc is the sale of 10,155 shares on February 24, 2025, which brought Christopher Heery around $647,787.
According to the SEC Form 4 filings, Christopher Heery has made a total of 0 transactions in Precision BioSciences Inc (DTIL) over the past 5 years. The most-recent trade in Precision BioSciences Inc is the acquisition of 83 shares on December 19, 2019, which cost Christopher Heery around $30,019.
Insider Trading History of Christopher Heery
- 1
Christopher Heery Trading Performance
GuruFocus tracks the stock performance after each of Christopher Heery's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Heery is -52.69%. GuruFocus also compares Christopher Heery's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Heery within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Heery's insider trading performs compared to the benchmark.
Performance of Christopher Heery
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.66 | | | | | |
| Relative Return to S&P 500(%) | -15.54 | | | | | |
Christopher Heery Ownership Network
Ownership Network List of Christopher Heery
Ownership Network Relation of Christopher Heery
Christopher Heery's Compensation Overview
| Company | Year | Salary($) | Bonus($) | Stock Awards($) | Option Awards($) | Equity Awards($) | Non-Equity Incentive Plan($) | All Other Compensation($) | Change in Pension and Deferred Comp($) | Total($) |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcellx Inc | 2023 | 480,960 | 192,000 | 1,537,785 | 1,639,028 | N/A | N/A | 10,440 | N/A | 3,860,213 |
| | | | | | | | | | |
Christopher Heery Owned Company Details
What does Precision BioSciences Inc do?
Who are the key executives at Precision BioSciences Inc?
Christopher Heery is the Chief Medical Officer of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include director & President and CEO Michael Amoroso , General Counsel Dario Scimeca , and 10 percent owner J. Jefferson Smith .
Precision BioSciences Inc (DTIL) Insider Trades Summary
Over the past 18 months, Christopher Heery made no insider transaction in Precision BioSciences Inc (DTIL). Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 31,440 shares made by Dario Scimeca , a net sale of 179,730 shares made by Michael Amoroso , and a net sale of 38,645 shares made by J. Jefferson Smith .
In summary, during the past 3 months, insiders sold 1,390 shares of Precision BioSciences Inc (DTIL) in total and bought 9,612 shares, with a net purchase of 8,222 shares. During the past 18 months, 70,606 shares of Precision BioSciences Inc (DTIL) were sold and 25,666 shares were bought by its insiders, resulting in a net sale of 44,940 shares.
Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Precision BioSciences Inc Insider Transactions
Christopher Heery Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Heery. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher Heery's mailing address is: Durham Nc 27701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
